tiprankstipranks
Trending News
More News >
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL

Compare Madrigal Pharmaceuticals (MDGL) vs. Competitors

Compare
1,337 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Madrigal Pharmaceuticals
$447.72
$10.27B
-45.32
31.06%
8 Buy
2 Hold
0 Sell
Strong Buy
Exelixis
$41.41
$10.75B
12.10
12.04%
6 Buy
7 Hold
1 Sell
Moderate Buy
Ionis Pharmaceuticals
$70.79
$11.69B
-33.22
115.10%
11 Buy
3 Hold
0 Sell
Strong Buy
Ascendis Pharma
$218.06
$13.38B
-50.22
31.37%
13 Buy
0 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$69.60
$13.49B
-20.69
100.17%
18 Buy
0 Hold
0 Sell
Strong Buy
Roivant Sciences
$27.93
$19.99B
-14.22
158.85%
8 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MDGL
Madrigal Pharmaceuticals
447.72
101.32
29.25%
EXEL
Exelixis
41.41
3.69
9.78%
IONS
Ionis Pharmaceuticals
70.79
37.34
111.63%
ASND
Ascendis Pharma
218.06
50.07
29.81%
BBIO
BridgeBio Pharma
69.60
32.38
87.00%
ROIV
Roivant Sciences
27.93
17.10
157.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts